Am J Transplant, Volume 16, Suppl 3 Archives - Page 143 of 180 - ATC Abstracts

2016 American Transplant Congress
An Analysis of Factors Associated with Pancreas Allograft Thrombosis.
J. Steggerda, K. Bornhurst, A. Annamalai, A. Peng, J. Mirocha, D. Dafoe.
Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
A successful simultaneous pancreas-kidney (SPK) transplant in recipients with end-stage diabetic nephropathy will provide normoglycemia and exert a salutary effect on neurovascular complications. Early, non-technical…
2016 American Transplant Congress
Planning Genitourinary Vascularized Composite Allotransplantation: A Pre-Operative Imaging Protocol.
I. Schol, T. Drijkoningen, G. Choy, R. Liu, C. Tanrikut, P. Holzer, D. Ko, C. Cetrulo.
Massachusetts General Hospital, Boston, MA.
Study purpose: To define the ideal pre-operative imaging protocol necessary for proper planning of a genitourinary vascularised composite allotransplantation (GUVCA) procedure.Methods: The multidisciplinary GUVCA team…
2016 American Transplant Congress
Everolimus Decline Anti-ABO Blood Type Antibody Titer in Desensitization for ABO Incompatible Kidney Transplantation.
Y. Wada, N. Fukuzawa, H. Harada.
Kidney Transplantation Surgery, Sapporo City General Hospital, Sapporo, Hokkaido, Japan.
INTRODUCTION: The immoderate donor shortage and sophisticated desensitization protocols resulted in the explosive increase and great success of the ABO blood type incompatible kidney transplantation…
2016 American Transplant Congress
Age-Based High GFR Associates with Clinical Risk Among Potential Living Donors, but Only with Increased Nephron Number Among Approved Donors.
H. Chakkera,¹ E. Poggio,³ A. Denic,² J. Mathew,² W. Kremers,² J. Larson,² H. Amer,² F. Cosio,² M. Stegall,² S. Taler,² A. Rule.²
¹Mayo Clinic, Arizona; ²Mayo Clinic, Rochester; ³Cleveland Clinic, OH.
Background:Association of high GFR with clinical and kidney structural characteristics among living donors has not been studied.Methods: Study cohort:potential kidney donors evaluated at Mayo Clinic…
2016 American Transplant Congress
Landscape of Hypertension Treatment in Former Kidney Donors.
L. Ferrara, O. Sanchez, D. Berglund, A. Matas, H. Ibrahim.
U of MN, Mpls.
The aim of this analysis is to describe the general epidemiological features for the development of hypertension and the most frequent medical therapies prescribed in…
2016 American Transplant Congress
Surveillance Biopsy Findings with Alemtuzumab (ALZ) Induction in Kidney Transplantation.
H. Madariaga,¹ R. Ugarte,¹ C. Drachenberg,² N. Costa,¹ B. Thomas,¹ J. Bromberg,³ M. Weir,¹ A. Haririan.¹
¹Department of Medicine, University of Maryland Medical Center, Baltimore, MD; ²Department of Pathology, University of Maryland Medical Center, Baltimore, MD; ³Department of Surgery, University of Maryland Medical Center, Baltimore, MD.
The risk of subclinical histological changes in renal allografts with ALZ induction is not well defined. Hence, we performed a retrospective analysis of 527 surveillance…
2016 American Transplant Congress
Immunological Ageing-Related Expansion of Highly Differentiated CD4⁺CD28null T Cells Is Associated with a Lower Risk for Early Acute Rejection After Renal Transplantation.
B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.
Internal Medicine, Nephrology and Transplantation, Erasmus MC, University Medical Centre, Rotterdam, Netherlands.
Background: End-stage renal disease patients have a dysfunctional, prematurely aged peripheral T-cell system. Here we hypothesized that the degree of premature T-cell ageing before kidney…
2016 American Transplant Congress
Comparative Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma (HCC-CCA) Undergoing Liver Transplantation: A Single Center Matched Cohort Analysis.
K. Lunsford, M. Harlander-Locke, J. Gornbein, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, R. Busuttil, V. Agopian.
Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Liver transplant (LT) is the gold standard for hepatocellular carcinoma (HCC) but is contraindicated in known HCC-CCA due to poor prognosis. We compared posttransplant oncologic…
2016 American Transplant Congress
Opioid-Sparing Pain Management Improves Outcomes and Safety in Living Liver Donors.
D. Ladner,¹ E. Pomfret,² M. Simpson,² J. Guarrera,³ R. Fisher,⁴ A. Skaro,¹ T. Baker,¹ T. Curtis,¹ A. Daud,¹ B. Platt,¹ R. Kang,¹ N. Salehitezangi,¹ J. Holl,¹ M. Abecassis,¹ D. Woods.¹
¹Northwestern University, Chicago, IL; ²Lahey Clinic, Burlington, MA; ³Columbia University, New York, NY; ⁴Virginia Commonwealth Univeristy, Richmond, VA.
BACKGROUND: As part of the ancillary four center study, to the Adult-to-Adult Living Donor Liver Transplant Cohort Study (A2ALL), over 75% of living liver donors…
2016 American Transplant Congress
Center and Surgeons' Experience Improves Outcome in Adult-to-Adult Living Donor Liver Transplantation: Validation of the Report of the A2ALL Consortium.
S. Nagai, A. Yoshida, M. Rizzari, K. Collins, D. Kim, M. Abouljoud.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI.
Background: Adult-to-adult living donor liver transplantation cohort study (A2ALL) has reported improved outcomes in centers with greater experience (>20 cases). The aim of this study…